文献速递类风湿关节炎

真实世界队列中难治性类风湿关节炎定义的比较表现及早晚期表型

Defining Difficult-to-Treat Rheumatoid Arthritis in Routine Care: Comparative Performance of Published Criteria and Description of Early and Late Difficult-to-Treat Rheumatoid Arthritis Phenotypes.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2026-09-15

该研究利用安大略最佳实践研究计划纵向真实世界类风湿关节炎(RA)注册数据,在1121例启动首个进阶治疗的患者中比较四种源自文献的EULAR难治性RA(D2T-RA)定义。结果显示不同定义识别的患者比例差异大(5.5%至11.7%),定义间重叠有限,提示这些标准不可互换;以首次进阶治疗启动为锚点的两年阈值可将约40%划为早期、约60%划为晚期D2T-RA。

要点

  • 四种D2T-RA定义捕获的患者比例从5.5%到11.7%不等,不能互换使用。
  • 仅44%的患者同时满足定义1至3,定义4与其他定义无重叠。
  • 以首次进阶治疗为锚点的两年阈值可区分早期与晚期D2T-RA表型。

核心结论

  • 已发表的EULAR D2T-RA标准应用方式不可互换,患者捕获范围差异大。
  • 以首次启动进阶治疗为锚点的两年阈值提供了临床均衡的早晚期D2T-RA框架。
  • 需要统一的多维定义并结合时间分层以改善表型划分与跨研究可比性。

研究设计与样本

  • 基于安大略最佳实践研究计划纵向真实世界RA注册数据,评估四种源自文献的EULAR D2T-RA定义。
  • 纳入1121例启动首个进阶治疗的RA患者,平均年龄56.0岁,80.7%为女性,平均病程8.4年。
  • 四种定义在疾病活动度要求、随访时长和治疗数量阈值上不同。

主要发现

  • 202例(18%)至少满足四种D2T-RA定义之一。
  • 各定义患病率从5.5%(定义4)到11.7%(定义2)不等。
  • 含多项疾病活动度指标的定义1和2识别患者比例最大,仅以启动第三种进阶治疗为标准的定义4最严格。
  • 仅44%的患者同时满足定义1至3,定义4与其他定义无重叠,提示捕获不同患者亚群。
  • 以首次进阶治疗启动为锚点、两年为阈值时,约40%为早期、约60%为晚期D2T-RA。

关键数值与推荐

  • 定义4仅以启动第三种进阶治疗界定,患病率5.5%。
  • 定义2患病率11.7%,为四种定义中最高。
  • 定义1和2纳入多项疾病活动度指标,识别患者比例最大。
  • 两年阈值以临床相关性和组间样本量均衡为依据选定。

临床怎么用

  • 临床或研究中使用D2T-RA定义时需注意不同应用方式捕获人群不同,不宜直接互换。
  • 可考虑以首次启动进阶治疗为时间锚点、两年为界区分早期与晚期D2T-RA以辅助表型分层。
  • 未来需采用整合疾病活动度与时间分层的统一多维定义以改善预后判断和跨研究比较。

局限性

  • 原文摘要未报告研究局限性相关信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite advances in treat-to-target strategies, a subset of patients with rheumatoid arthritis (RA) remains refractory to multiple therapies and is classified as having difficult-to-treat RA (D2T-RA). Although EULAR has proposed classification criteria for D2T-RA, these patients remain variably identified in real-world practice because of heterogeneous applications. We aimed to compare the preformance of published applications of the EULAR D2T-RA criteria in a real-world RA cohort and to determine weather the timing of D2T-RA development could distinguish early from late D2T-RA phenotypes. METHODS: Using data from the Ontario Best Practices Research Initiative, a longitudinal real-world RA registry, we evaluated four literature-derived adaptations of the EULAR D2T-RA definition among patients initiating their first advanced therapy. These definitions differed in disease activity requirements, follow-up duration, and treatment count thresholds. We assessed prevalence, agreement between definitions, and explored different temporal anchors for classifying early versus late D2T-RA. RESULTS: Among 1,121 patients with RA (mean age 56.0 years; 80.7% female; mean disease duration of 8.4 years), 202 (18%) fulfilled at least one of four D2T-RA definitions. Prevalence varied substantially across definitions, ranging from 5.5% (definition 4) to 11.7% (definition 2). Definitions 1 and 2, which incorporated multiple disease activity measures, identified the largest proportion of patients, whereas definition 4, which is defined solely by initiation of a third advanced therapy, was most restrictive. Overlap between definitions was modest, with only 44% of patients meeting all definitions 1 through 3, whereas definition 4 identified a distinct group with no overlap with the other definitions, suggesting that these classification approaches capture different patient subsets and are not interchangeable. In temporal analyses, anchoring the D2T-RA onset to the initiation of the first advanced therapy, a two-year threshold-selected for its clinical relevance and balanced group sizes-classified approximately 40% of patients as early and approximately 60% as late D2T-RA. CONCLUSION: The applications of D2T-RA criteria are not interchangeable and vary widely in patient capture. A two-year threshold anchored to the first initiation of advanced therapy offered a clinically balanced early-late D2T-RA framework. Harmonized, multidimensional definitions incorporating disease activity and temporal stratification are needed to improve phenotyping, prognostication, and cross-study comparability.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Attar RZ, Movahedi M, Cesta A, et al. Defining Difficult-to-Treat Rheumatoid Arthritis in Routine Care: Comparative Performance of Published Criteria and Description of Early and Late Difficult-to-Treat Rheumatoid Arthritis Phenotypes. Arthritis Care Res (Hoboken). 2026. PMID: 42742031. doi:10.1002/acr.80161

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。